MARKET

ONVO

ONVO

Organovo Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7127
-0.0328
-4.40%
Opening 12:02 08/12 EDT
OPEN
0.7200
PREV CLOSE
0.7455
HIGH
0.7477
LOW
0.7026
VOLUME
603.47K
TURNOVER
--
52 WEEK HIGH
0.9300
52 WEEK LOW
0.1933
MARKET CAP
93.09M
P/E (TTM)
-6.1334
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ONVO stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.

EPS

ONVO News

More
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 07/06 09:18
Hedge Fund Sentiment Is Stagnant On Organovo Holdings Inc (ONVO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These fi
Insider Monkey · 06/10 19:43
The Top Stocks To Buy Now
Seeking Alpha - Article · 05/09 00:41
Organovo Up On Cancelled Merger, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 04/09 11:52
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
Benzinga · 04/08 12:53
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7)
Benzinga · 04/08 11:53
Edited Transcript of ONVO earnings conference call or presentation 9-Nov-17 10:00pm GMT
Thomson Reuters StreetEvents · 04/08 07:43
Organovo stockholders nix Tarveda merger; shares up 2% after hours
seekingalpha · 04/08 01:38

Industry

Biotechnology & Medical Research
+0.08%
Pharmaceuticals & Medical Research
+1.45%

Hot Stocks

Symbol
Price
%Change

About ONVO

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.
More

Webull offers kinds of Organovo Holdings Inc stock information, including NASDAQ:ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ONVO stock methods without spending real money on the virtual paper trading platform.